Noninvasive imaging of pancreatic Β cells

Nature Reviews Endocrinology

Volumn 5, Issue 7, 2009, Pages 394-400

  Malaisse, Willy J ^a   Louchami, Karim ^a   Sener, Abdullah ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROTETRABENAZINE; FLUORODEOXYGLUCOSE F 18; GANGLIOSIDE; GLIBENCLAMIDE; GLUCOSE; GLYCOGEN; IODINE 125; MANNOHEPTULOSE; MITIGLINIDE; MONOCLONAL ANTIBODY; ZINC 65; DIAGNOSTIC AGENT; DRUG DERIVATIVE; TETRABENAZINE;

CELL DENSITY; CELL LABELING; FUNCTIONAL MORPHOLOGY; HUMAN; HYPERGLYCEMIA; IMAGING; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET BETA CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; CYTOLOGY; DIAGNOSTIC IMAGING; METHODOLOGY; PATHOLOGY; STAINING;

DIAGNOSTIC IMAGING; HUMANS; INSULIN-SECRETING CELLS; STAINING AND LABELING; TETRABENAZINE;

EID: 69449083658     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.103     Document Type: Review

References (65)

1. Wild, S., Roglic, G., Green, A., sicree, R. & King, H. Global prevalence of diabetes. estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047-1053 (2004).
2. Robertson, R. P. estimation of â-cell mass by metabolic tests. Necessary, but how sufficient? Diabetes 56, 2420-2424 (2007).
3. Bouwens, L. & Rooman, I. regulation of pancreatic â-cell mass. Physiol. Rev. 85, 1255-1270 (2005).
4. Malaisse, W. J. On the track to the â-cell. Diabetologia 44, 393-406 (2001).
5. Malaisse, W. J. Non-invasive imaging of the endocrine pancreas. Int. J. Mol. Med. 15, 243-246 (2005).
6. Paty, B. W., Bonner-Weir, S., Laughlin, M. R., Mcewan, A. J. & shapiro, A. M. Toward development of imaging modalities for islet after transplantation: insights from the National institutes of Health workshop on â Cell imaging. Transplantation 77, 1133-1137 (2004).
7. Souza, F. et al. Current progress in non-invasive imaging of â cell mass of the endocrine pancreas. Curr. Med. Chem. 13, 2761-2773 (2006).
8. Lin, M. et al. Advances in molecular imaging of pancreatic â cells. Front. Biosci. 13, 4558-4575 (2008).
9. saudek, F., Brogren, C. H. & Manohar, s. imaging the â-cell mass: why and how. Rev. Diabet. Stud. 5, 6-12 (2008).
10. Holmberg, D. & Ahlgren, U. imaging the pancreas: from ex vivo to non-invasive technology. Diabetologia 51, 2148-2154 (2008).
11. Medarova, Z. & Moore, A. Non-invasive detection of transplanted pancreatic islets. Diabetes Obes. Metab. 10 (Suppl. 4), 88-97 (2008).
12. Malaisse, w. J., Ladrière, L. & Malaisse-Lagae, Pancreatic fate of 6-deoxy-6-[125i]iodo-d-glucose: in vivo experiments. Endocrine 13, 95-101 (2000). (Pubitemid 30701640)
13. Ladrière, L., Malaisse-Lagae, F. & Malaisse, W. Pancreatic uptake of 65Zn in control and streptozotocin-injected rats. Med. Sci. Res. 28, 43-44 (2000).
14. Ladrière, L., Malaisse-Lagae, F. & Malaisse, W. Uptake of tritiated glibenclamide by endocrine and exocrine pancreas. Endocrine 13, 133-136 (2000). (Pubitemid 30701646)
15. Malaisse, W. J. & Malaisse-Lagae, F. Uptake of tritiated mitiglinide by pancreatic pieces and islets. Diabetes Res. 35, 51-59 (2000).
16. Ladrière, L., Malaisse-Lagae, F., Alejandro, R. & Malaisse, W. J. Pancreatic fate of a 125i-labelled mouse monoclonal antibody directed against pancreatic â-cell surface ganglioside(s) in control and diabetic rats. Cell Biochem. Funct. 19, 107-115 (2001).
17. Doherty, M. & Malaisse, W. J. Glycogen accumulation in rat pancreatic islets. In vivo experiments. Endocrine 14, 303-309 (2001).
18. Ladrière, L., Leclercq-Meyer, V. & Malaisse, W. J. Assessment of islet â-cell mass in isolated rat pancreases perfused with d-[3H] mannoheptulose. Am. J. Physiol. Endocrinol. Metab. 281, e298-e303 (2001).
19. Malaisse, W. J., Courtois, P., Kadiata, M. M. & Sener, A. GLUT2-mediated transport of d-mannoheptulose:A tool for imaging of the endocrine pancreas? Diabetes 49 (Suppl. 1), A418 (2000).
20. Simon, E. J. & Kraicer, P. F. The blockade of insulin secretion by mannoheptulose. Isr. J. Med. Sci. 2, 785-799 (1966).
21. Simon, E., Frenkel, G. & Kraicer, P. F. Blockade of insulin secretion by mannoheptulose. Isr. J. Med. Sci. 6, 743-752 (1972).
22. Lev-Ran, A., Laor, J., Vins, M. & Simon, E. effect of intravenous infusion of d-mannoheptulose on blood glucose and insulin levels in man. J. Endocrinol. 47, 137-138 (1970).
23. Paulsen, E. P. Mannoheptulose and insulin inhibition. Ann. NY Acad. Sci. 150, 455-456 (1968).
24. Otaga, J. N., Kawano, Y., Bevenue, A. & Casaret, J. L. The ketoheptose content of some tropical fruits. J. Agric. Food Chem. 29, 113-115 (1972).
25. Viktora, J. K., Johnson, B. F., Penhos, J. C., Rosenberg, C. A. & Wolff, F. W. effect of ingested mannoheptulose in animals and man. Metabolism 18, 87-102 (1969).
26. Johnson, B., Viktora, J. & Wolff, F. The efficacy of oral mannoheptulose in monkey and man [abstract]. Diabetes 18 (Suppl. 1), 360 (1969).
27. Garber, A. J. in Internal Medicine 3rd edn Ch. 343 (ed stein, J. H.) 2273-2278 (Little & Brown, Boston, 1990).
28. Bergh, B. O. The avocado and human nutrition. 1. some human health aspects of the avocado. in Proc. 2nd World Avocado Congress, 1991 April 21-26; Orange, CA (eds Lovatt, C. J. et al.) 25-35 (University of California, riverside, 1992).
29. Mohamed-Yasseen, Y. Uncommon uses of avocado. Tropical Fruit News 28, 14 (1994).
30. Sener, A. et al. d-mannoheptulose uptake and its metabolic and secretory effects in human pancreatic islets. Int. J. Mol. Med. 6, 617-620 (2000).
31. Ferrer, J., Benito, C. & Gomis, R. Pancreatic islet GLUT2 glucose transporter mrNA and protein expression in humans with and without NiDDM. Diabetes 44, 1369-1374 (1995).
32. De Vos, A. et al. Human and rat â cells differ in glucose transporter but not in glucokinase gene expression. J. Clin. Invest. 96, 2489-2495 (1995).
33. Malaisse, W. J., Doherty, M., Ladrière, L. & Malaisse-Lagae, F. Pancreatic uptake of 2-[14C] alloxan. Int. J. Mol. Med. 7, 311-315 (2001).
34. ran, C., Pantazopoulos, P., Medarova, Z. & Moore, A. synthesis and testing of â-cell-specific streptozotocin-derived near-infrared imaging probes. Angew Chem. Int. Ed. Engl. 46, 8998-9001 (2007).
35. Sweet, I. R., Cook, L., Lernmark, A., Greenbaum, C. J. & Krohn, K. A. Non-invasive imaging of â cell mass:A quantitative analysis. Diabetes Technol. Ther. 6, 625-629 (2004).
36. Wängler, B. et al. synthesis and evaluation of (s.)-2-(2-[18F] fluoroethoxy)-4-([3-methyl-1-(2- piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl) - benzoic acid ([18F]repaglinide):A promising radioligand for quantification of pancreatic â-cell mass with positron emission tomography (PeT). Nucl. Med. Biol. 31, 639-647 (2004).
37. Moore, A., Bonner-Weir, S. & Weissleder, R. Noninvasive in vivo measurement of â-cell mass in mouse model of diabetes. Diabetes 50, 2231-2236 (2001).
38. Paty, B. W. et al. â Cell 125i-labeled iC2 antibody is a promising method of measuring intra- hepatically-transplanted islet mass in vivo [abstract 45]. Presented at imaging the Pancreatic â Cell, 2003 April 21-22, Bethesda, MD.
39. Otonkoski, T. et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with 18F-DOPA positron emission tomography. Diabetes 55, 13-18 (2006).
40. Kauhanen, S. et al. 18F-l-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or â-cell hyperplasia in adult patients. J. Clin. Endocrinol. Metab. 92, 1237-1244 (2007).
41. Amartey, J. K., esguerra, C., Al-Jammaz, i., Parhar, r. s. & Al-Otaibi, B. synthesis and evaluation of radioiodinated substituted â-naphthylalanine as a potential probe for pancreatic â-cells imaging. Appl. Radiat. Isot. 64, 769-777 (2006).
42. Evgenov, N. V., Medarova, Z., Dai, G., Bonner-Weir, S. & Moore, A. In vivo imaging of islet transplantation. Nat. Med. 12, 144-148 (2006).
43. Evgenov, N. V. et al. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes 55, 2419-2428 (2006).
44. Evgenov, N. V., Pratt, J., Pantazopoulos. P. & Moore, A. effects of glucose toxicity and islet purity on in vivo magnetic resonance imaging of transplanted pancreatic islets. Transplantation 85, 1091-1098 (2008).
45. Koblas, T. et al. Magnetic resonance imaging of intrahepatically transplanted islets using paramagnetic beads. Transplant. Proc. 37, 3493-3495 (2005).
46. Toso, C. et al. Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling. Am. J. Transplant. 8, 701-706 (2008).
47. Medarova, Z. et al. Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes. Diabetes 56, 2677-2682 (2007).
48. Medarova, Z., Bonner-Weir, S., Lipes, M. & Moore, A. imaging â-cell death with a near- infrared probe. Diabetes 54, 1780-1788 (2005).
49. Srinivas, M., Morel, P. A., Ernst, L. A., Laidlaw, D. H. & Ahrens, E. T. 19F-Mri for visualization and quantification of cell migration in a diabetes model. Magn. Reson. Med. 58, 725-734 (2007).
50. Medarova, Z., Tsai, S., Evgenov, N., Santamaria, P. & Moore, A. In vivo imaging of a diabetogenic CD8+ T cell response during type 1 diabetes progression. Magn. Reson. Med. 59, 712-720 (2008).
51. Maffei, A. et al. identification of tissue-restricted transcripts in human islets. Endocrinology 145, 4513-4521 (2004).
52. Simpson, N. R. et al. visualizing pancreatic â-cell mass with 11C-DTBZ. Nucl. Med. Biol. 33, 855-864 (2006).
53. Souza, F. et al. Longitudinal non-invasive PeT- based â cell mass estimates in a spontaneous diabetes rat model. J. Clin. Invest. 116, 1506-1513 (2006).
54. Kung M.-P. et al. In vivo imaging of â-cell mass in rats using 18F-FP-(+)-DTBZ:A potential PeT ligand for studying diabetes mellitus. J. Nucl. Med. 49, 1171-1176 (2008).
55. Goland, R. et al. 11C-DTBZ PeT imaging of the pancreas in subjects with longstanding type 1 diabetes and healthy controls. J. Nucl. Med. 50, 382-389 (2008).
56. Harris, P. E. et al. VMAT2 gene expression and function as it applies to imaging â-cell mass. J. Mol. Med. 86, 5-16 (2008).
57. Raffo, A. et al. role of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazine. J. Endocrinol. 198, 1-10 (2008).
58. Saisho, Y. et al. relationship between pancreatic vesicular monoamine transporter 2 (vMAT2) and insulin expression in human pancreas. J. Mol. Histol. 39, 543-551 (2008).
59. Nyqvist, D., Köhler, M., Wahlstedt, H. & Berggren, P.-O. Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes 54, 2287-2293 (2005).
60. Speier, S. et al. Noninvasive high-resolution in vivo imaging of cell biology in the anterior chamber of the mouse eye. Nat. Protoc. 3, 1278-1286 (2008).
61. Alanentalo, T. et al. Tomographic molecular imaging and 3D quantification within adult mouse organs. Nat. Methods 4, 31-33 (2006).
62. Le Bihan, D., Urayama, S.-I., Aso, T., Hanakawa, T. & Fukuyama, H. Direct and fast detection of neuronal activation in the human brain with diffusion Mri. Proc. Natl Acad. Sci. USA 103, 8263-8268 (2006).
63. Le Bihan, D. see the thinking brain:A story about water [French]. Bull. Mem. Acad. R. Med. Belg. 163, 105-121 (2008).
64. Miley, H. E., Sheader, E. A., Brown, P. D. & Best, L. Glucose-induced swelling in rat pancreatic â-cells. J. Physiol. 504 (Pt 1), 191-196 (1997).
65. Malaisse, W. J. see the thinking brain:A story about water [French]. Bull. Mem. Acad. R. Med. Belg. 163, 121-122 (2008).